These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 457017

  • 1. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
    Arntz HR, Dreykluft HR, Leonhardt H.
    Fortschr Med; 1979 Jul 19; 97(27):1212-4. PubMed ID: 457017
    [Abstract] [Full Text] [Related]

  • 2. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
    Mertz DP.
    MMW Munch Med Wochenschr; 1978 Oct 20; 120(42):1387-90. PubMed ID: 101792
    [Abstract] [Full Text] [Related]

  • 3. [Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
    Fortschr Med; 1979 May 03; 97(17):835-6. PubMed ID: 437646
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)].
    Matzkies F, Berg G.
    Dtsch Med Wochenschr; 1976 Oct 22; 101(43):1568-70. PubMed ID: 991731
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S, Osiri M, Deesomchok U, Avihingsanon Y.
    J Med Assoc Thai; 2004 Sep 22; 87(9):1087-91. PubMed ID: 15516011
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H.
    Z Gesamte Inn Med; 1990 Dec 01; 45(23):719-20. PubMed ID: 2102029
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P, Akkasilpa S, Deesomchok U.
    J Med Assoc Thai; 2002 Jun 01; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
    Mertz DP.
    Fortschr Med; 1983 May 12; 101(18):851-3. PubMed ID: 6862346
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The correction of hyperuricemia in patients with different forms of nephrolithiasis using allopurinol and Allomaron].
    Darenkov AF, Konstantinova OV, Ianenko EK.
    Urol Nefrol (Mosk); 1994 May 12; (5):35-7. PubMed ID: 7871619
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Reducing the risks in the treatment of gout and hyperuricaemia (author's transl)].
    Mertz DP.
    Dtsch Med Wochenschr; 1976 Aug 27; 101(35):1288-92. PubMed ID: 782809
    [No Abstract] [Full Text] [Related]

  • 16. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K, Kato M, Furuse Y, Kinugasa Y, Ishida K, Osaki S, Kinugawa T, Igawa O, Hisatome I, Shigemasa C, Anker SD, Doehner W.
    Circ Heart Fail; 2010 Jan 27; 3(1):73-81. PubMed ID: 19933411
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A.
    Arthritis Rheum; 2002 Aug 27; 47(4):356-60. PubMed ID: 12209479
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.